Your browser doesn't support javascript.
loading
Clinical value of metabolic PET parameters of primary vulvar carcinoma.
Yanarates, Ahmet; Budak, Emine; Budak, Adnan; Inan, Abdurrahman Hamdi; Kanmaz, Ahkam Göksel; Oral, Aylin; Yazici, Bulent.
Affiliation
  • Yanarates A; University of Health Sciences, Izmir Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, Department of Nuclear Medicine, Izmir, Turkey. Electronic address: ahmetyanarates@gmail.com.
  • Budak E; University of Health Sciences, Izmir Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, Department of Nuclear Medicine, Izmir, Turkey.
  • Budak A; Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, Izmir, Turkey.
  • Inan AH; Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, Izmir, Turkey.
  • Kanmaz AG; Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, Izmir, Turkey.
  • Oral A; Ege University Medical Faculty, Department of Nuclear Medicine, Izmir, Turkey.
  • Yazici B; Ege University Medical Faculty, Department of Nuclear Medicine, Izmir, Turkey.
Article de En | MEDLINE | ID: mdl-34752370
PURPOSE: We aim to establish the prognostic value of metabolic parameters of the primary tumor in patients diagnosed with vulvar squamous cell carcinoma (VSCC) who underwent a pretreatment F-18 FDG PET/CT scan. MATERIALS AND METHODS: This retrospective study included 47 patients with a histopathologically confirmed diagnosis of VSCC, and who underwent a F-18 FDG PET/CT scan prior to treatment. The disease stage and age at diagnosis, and the maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) values of the primary tumor, based on a baseline PET scan, were recorded. The relationship between these factors, and progression-free survival (PFS) and overall survival (OS) was evaluated. RESULTS: The mean age of the 47 study patients was 69.6±1.9 years. Among the patients, 18 were in early stage of the disease and 29 were in the advanced stage. The age, and SUVmax, SUVmean, MTV and TLG values were statistically significantly associated with OS and PFS. Furthermore, it was noted that OS and PFS were significantly longer in the early stage patients than in the advanced stage patients, in patients with a tumor size <4cm than those with a tumor size ≥4cm, and in patients with a negative lymph node metastasis than those with a positive lymph node metastasis. CONCLUSION: Our findings suggest that PET parameters are prognostic factors for VSCC. To the best of our knowledge, this study is the first to investigate the prognostic value of the PET parameters of primary tumors in patients with VSCC, and as such, we believe it contributes to literature.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vulve / Carcinome épidermoïde / Radiopharmaceutiques / Fluorodésoxyglucose F18 / Tomographie par émission de positons couplée à la tomodensitométrie Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans Langue: En Journal: Rev Esp Med Nucl Imagen Mol (Engl Ed) Année: 2021 Type de document: Article Pays de publication: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vulve / Carcinome épidermoïde / Radiopharmaceutiques / Fluorodésoxyglucose F18 / Tomographie par émission de positons couplée à la tomodensitométrie Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans Langue: En Journal: Rev Esp Med Nucl Imagen Mol (Engl Ed) Année: 2021 Type de document: Article Pays de publication: Espagne